TSMC, Samsung Diverge at 7nm
TSMC's 7nm SRAM sees "healthy" yields
Rick Merritt, EETimes
2/8/2017 00:01 AM EST
SAN FRANCISCO — Samsung and TSMC gave two very different glimpses of their work on 7nm process technology at the International Solid State Circuits Conference (ISSCC) here. Both companies presented work on SRAMs, typically a key driver for next-generation nodes.
TSMC’s paper described a test chip that could pass for a commercial part and said it had “healthy” yields. Samsung described its use of extreme ultraviolet (EUV) lithography to repair what was clearly a research device, suggesting what it will call 7nm could still be years away.
Both papers need to be viewed through the lens of ISSCC, a gathering place for some 3,000 upwardly mobile chip designers from around the world. Both foundries want to make the case they are at the leading edge of next-generation foundry services. Unfortunately they diverge on what they will call 7nm.
|
|
E-mail This Article |
|
Printer-Friendly Page |
Related News
- TSMC, GF/Samsung Battle at 7nm
- Will 1.4-nm help Samsung catch up with TSMC, IFS?
- M31 demonstrates high-speed interface IP development achievements on TSMC's 7nm & 5nm process technologies
- Flex Logix EFLX4K eFPGA IP Core on TSMC 7nm Technology Now Available
- MediaTek and TSMC Unveil the World's First 7nm 8K Resolution Digital TV System-on-Chip
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






